Rate of Multidrug-resistance to Antimicrobial Drugs in Patients in Pediatric Neurointensive Care

Overview

Journal Indian J Crit Care Med

Specialty Critical Care

Date 2023 Feb 9

PMID 36756473

Authors

Swapnil Patel

Hemanshu Prabhakar

Indu Kapoor

Affiliations

Soon will be listed here.

Abstract

Background: Multidrug-resistant (MDR) organisms in the critical care unit are a worldwide concern. The vulnerability to MDR infection in pediatric patients admitted in neurocritical care are due to altered mental status, immature immune system, higher risk of aspiration, and more frequent use of invasive devices. We aimed to measure the burden of MDR infection in pediatric neurosurgical intensive care unit (NSICU) patients.

Methods: All pediatric patients between 1 and 18 years for intracranial and spine surgeries admitted for more than 48 hours in NSICU were enrolled in the study. If patients showed a clinical picture of pneumonia, bloodstream infection (BSI), or urinary tract infection (UTI) after receiving mechanical ventilation or an indwelling device for at least 48 hours, samples of tracheal aspirates, urine, blood, and cerebrospinal fluid (CSF) were sent for microbiological culture. We noted the type of organism, MDR infection rate, and associated risk factors. Pearson Chi-squared test and Fisher's test were used for statistical analysis; < 0.05 was considered statistically significant.

Results: A total of 274 pediatric patients were studied. In 1 year, there was a total of 1,790 patient days. The inclusive MDR infection rate was 17.3/1,000 patient days. Also, (38.7%) was the commonest MDR pathogen. The commonest source of infection was BSI (32.3%). The risk factors associated with MDR infections were the length of stay in NSICU, mechanical ventilation of more than 5 days, emergency surgery, respiratory and cardiac comorbidities, and poor nutrition status ( < 0.05).

Conclusion: The MDR infection rate in our study was 17.3/1,000 patient days in pediatric patients. Also, was found to be the commonest MDR pathogen. Bloodstream was the commonest source of infection.

How To Cite This Article: Patel S, Prabhakar H, Kapoor I. Rate of Multidrug-resistance to Antimicrobial Drugs in Patients in Pediatric Neurointensive Care. Indian J Crit Care Med 2023;27(1):67-72.

Citing Articles

Drug-resistant Pantoea agglomerans Causing Bacteremia at a Tertiary Care Hospital in Kolkata, India: First Report of Carbapenem Resistance Mediated by OXA-181.

Mallick A, Sarkar S, Lopes B, Das S Curr Microbiol. 2024; 81(11):389.

PMID: 39367887 DOI: 10.1007/s00284-024-03888-2.

Multidrug Resistance: The Growing Menace in PICU.

Kamath S Indian J Crit Care Med. 2023; 27(1):6-7.

PMID: 36756471 PMC: 9886043. DOI: 10.5005/jp-journals-10071-24394.

References

Esteban E, Ferrer R, Urrea M, Suarez D, Rozas L, Balaguer M . The impact of a quality improvement intervention to reduce nosocomial infections in a PICU. Pediatr Crit Care Med. 2013; 14(5):525-32. DOI: 10.1097/PCC.0b013e31828a87cc. View

Muto C, Giannetta E, Durbin L, Simonton B, Farr B . Cost-effectiveness of perirectal surveillance cultures for controlling vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol. 2002; 23(8):429-35. DOI: 10.1086/502080. View

Huang X, Li G, Yi L, Li M, Wang J . [The epidemiology of multidrug-resistant bacteria colonization and analysis of its risk factors in intensive care unit]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015; 27(8):667-71. DOI: 10.3760/cma.j.issn.2095-4352.2015.08.010. View

Tfifha M, Ferjani A, Mallouli M, Mlika N, Abroug S, Boukadida J . Carriage of multidrug-resistant bacteria among pediatric patients before and during their hospitalization in a tertiary pediatric unit in Tunisia. Libyan J Med. 2017; 13(1):1419047. PMC: 5757224. DOI: 10.1080/19932820.2017.1419047. View

Potocki M, Goette J, Szucs T, Nadal D . Prospective survey of antibiotic utilization in pediatric hospitalized patients to identify targets for improvement of prescription. Infection. 2004; 31(6):398-403. DOI: 10.1007/s15010-003-4130-1. View

Giantsou E, Liratzopoulos N, Efraimidou E, Panopoulou M, Alepopoulou E, Kartali-Ktenidou S . Both early-onset and late-onset ventilator-associated pneumonia are caused mainly by potentially multiresistant bacteria. Intensive Care Med. 2005; 31(11):1488-94. DOI: 10.1007/s00134-005-2697-y. View

Rhim H, Won S, Kashefiolasl S, Brawanski N, Hattingen E, Berkefeld J . Multidrug-resistant organisms (MDROs) in patients with subarachnoid hemorrhage (SAH). Sci Rep. 2021; 11(1):8309. PMC: 8050277. DOI: 10.1038/s41598-021-87863-y. View

Magiorakos A, Srinivasan A, Carey R, Carmeli Y, Falagas M, Giske C . Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2011; 18(3):268-81. DOI: 10.1111/j.1469-0691.2011.03570.x. View

Ostrowsky B, Trick W, Sohn A, Quirk S, Holt S, Carson L . Control of vancomycin-resistant enterococcus in health care facilities in a region. N Engl J Med. 2001; 344(19):1427-33. DOI: 10.1056/NEJM200105103441903. View

10.

Gastmeier P, Sohr D, Just H, Nassauer A, Daschner F, Ruden H . How to survey nosocomial infections. Infect Control Hosp Epidemiol. 2000; 21(6):366-70. DOI: 10.1086/501774. View

11.

El-Nawawy A, Ashraf G, Antonios M, Meheissen M, El-Alfy M . Incidence of Multidrug-Resistant Organism Among Children Admitted to Pediatric Intensive Care Unit in a Developing Country. Microb Drug Resist. 2018; 24(8):1198-1206. DOI: 10.1089/mdr.2017.0414. View

12.

Ylipalosaari P, Ala-Kokko T, Laurila J, Ohtonen P, Syrjala H . Intensive care acquired infection is an independent risk factor for hospital mortality: a prospective cohort study. Crit Care. 2006; 10(2):R66. PMC: 1550870. DOI: 10.1186/cc4902. View

13.

Allel K, Garcia P, Labarca J, Munita J, Rendic M, Undurraga E . Socioeconomic factors associated with antimicrobial resistance of , , and in Chilean hospitals (2008-2017). Rev Panam Salud Publica. 2020; 44:e30. PMC: 7498296. DOI: 10.26633/RPSP.2020.30. View

14.

Wang Z, Xia Z . What we can do? The risk factors for multi-drug resistant infection in pediatric intensive care unit (PICU): a case-control study. Ital J Pediatr. 2020; 46(1):17. PMC: 7007655. DOI: 10.1186/s13052-019-0769-9. View

15.

Siwakoti S, Subedi A, Sharma A, Baral R, Bhattarai N, Khanal B . Incidence and outcomes of multidrug-resistant gram-negative bacteria infections in intensive care unit from Nepal- a prospective cohort study. Antimicrob Resist Infect Control. 2018; 7:114. PMC: 6158849. DOI: 10.1186/s13756-018-0404-3. View

16.

Magill S, OLeary E, Janelle S, Thompson D, Dumyati G, Nadle J . Changes in Prevalence of Health Care-Associated Infections in U.S. Hospitals. N Engl J Med. 2018; 379(18):1732-1744. PMC: 7978499. DOI: 10.1056/NEJMoa1801550. View

17.

Agarwal R, Mohapatra S, Rath G, Kapil A . Active Surveillance of Health Care Associated Infections in Neurosurgical Patients. J Clin Diagn Res. 2017; 11(7):DC01-DC04. PMC: 5583837. DOI: 10.7860/JCDR/2017/26681.10146. View

18.

Lawrence R, Jeyakumar E . Antimicrobial resistance: a cause for global concern. BMC Proc. 2013; 7(Suppl 3):S1. PMC: 3892153. DOI: 10.1186/1753-6561-7-S3-S1. View

19.

Urrea M, Pons M, Serra M, Latorre C, Palomeque A . Prospective incidence study of nosocomial infections in a pediatric intensive care unit. Pediatr Infect Dis J. 2003; 22(6):490-4. DOI: 10.1097/01.inf.0000069758.00079.d3. View

20.

Abbas Q, Haq A, Kumar R, Ali S, Hussain K, Shakoor S . Evaluation of antibiotic use in Pediatric Intensive Care Unit of a developing country. Indian J Crit Care Med. 2016; 20(5):291-4. PMC: 4876651. DOI: 10.4103/0972-5229.182197. View